Rectify & Boehringer Ingelheim: CKD Partnership | BioWorld

by Archynetys Health Desk

Rectify Pharmaceuticals Inc. has entered a strategic research and licensing agreement with Boehringer Ingelheim Pharma GmbH & Co.

Related Posts

Leave a Comment